SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-05-019799
Filing Date
2005-06-23
Accepted
2005-06-23 17:25:03
Documents
9
Period of Report
2005-06-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v020585.htm 8-K 33646
2 v020585_ex10-1.htm EX-10.1 376922
3 v020585_ex10-2.htm EX-10.2 36627
4 v020585_ex10-3.htm EX-10.3 180214
5 v020585_ex10-4.htm EX-10.4 148627
6 v020585_ex10-5.htm EX-10.5 51864
7 v020585_ex10-6.htm EX-10.6 51564
8 v020585_ex10-7.htm EX-10.7 159426
9 v020585_ex10-8.htm EX-10.8 112832
  Complete submission text file 0001144204-05-019799.txt   1153356
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10113 | Film No.: 05913246
SIC: 2834 Pharmaceutical Preparations